Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-25-040443
Filing Date
2025-08-14
Accepted
2025-08-14 20:31:39
Documents
2
Period of Report
2025-08-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1755217894.html 3  
1 FORM 3 wk-form3_1755217894.xml 3 1706
2 EX-24 ex24craigpowerofattorney.htm EX-24 6688
  Complete submission text file 0001628280-25-040443.txt   9982
Mailing Address C/O X4 PHARMACEUTICALS, INC. 61 NORTH BEACON STREET, 4TH FLOOR BOSTON MA 02134
Business Address
Craig Adam R (Reporting) CIK: 0001339498 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38295 | Film No.: 251222039

Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Issuer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)